CVR Energy Inc. (CVI)

CVR Energy Q2 Revenue Beats by 4%

- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency - FDA decision expe...

CVR Energy faced weak refining margins and high turnaround costs, but improving crack spreads and cost efficiencies offer cautious optimism for a rebound. Turnaround-related headwinds are largely behi...

CVR Energy, Inc. (NYSE:CVI ) Q2 2025 Earnings Conference Call July 31, 2025 1:00 PM ET Company Participants Dane J. Neumann - Executive VP, CFO, Treasurer & Assistant Secretary David L.

CVR Energy (CVI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.09 per share a year ago.

Carl Icahn-backed CVR Energy on Wednesday named Mark Pytosh as chief executive officer and appointed Brett Icahn to its board.

Here's a preview of what to expect from energy stocks CRK, CVI, PUMP, AM and AR ahead of their quarterly earnings reports, set to be released tomorrow.

CVR (CVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BEAUFORT, S.C.--(BUSINESS WIRE)-- #CVD--A new report published by THE SAGE GROUP quantifies CVD prevalence and incidence for the 2020-2040 period. “Chronic venous disease afflicts 1.5 times as many pe...

With the 10-year U.S. Treasury bond currently yielding 4.38%, interest rates are still abnormally high given positive job growth, trillions of dollars in U.S.